A股收評:5連跌!深證成指險守10000點,珠寶首飾、核電板塊逆市活躍
A股三大指數今日震盪走低,且均錄得5連跌;截至收盤,滬指跌0.02%報3339點,深證成指跌0.26%,創業板指跌0.31%,北證50指數跌1.39%。全天成交1.03萬億元,較前一交易日增量98億元,全市場近3500股上升。盤面上,珠寶首飾板塊走高,明牌珠寶等多股升停;核電、可控核聚變板塊反覆活躍,雪人股份等多股升停;啤酒概念拉昇,樂惠國際升停;乳業板塊走強,新乳業升停;海工裝備、毛髮醫療及可燃冰等板塊升幅居前。另外,重組蛋白板塊走低,三生國健跌超8%;化肥板塊回落,湖北宜化領跌;環氧丙烷走弱,紅牆股份跌超6%;SPD概念、CRO及化學原料等板塊跌幅居前。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.